Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-17

FDA Approved: HYDRALAZINE HYDROCHLORIDE — Original Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approves the Hydralazine hydrochloride original application from Baxter Healthcare Corporation, granting generic approval for the treatment of hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydralazine hydrochloride (Hydralazine hydrochloride)

Snippet

ORIG AP for HYDRALAZINE HYDROCHLORIDE (HYDRALAZINE HYDROCHLORIDE)